Who is sponsoring NCT04762251?

NCT04762251 is sponsored by University of Adelaide.

What drugs are being tested in NCT04762251?

Interventions in NCT04762251: Time-restricted eating, Current Best Practice.

What condition does NCT04762251 study?

NCT04762251 studies Time-restricted Eating, Diet Quality.

Is NCT04762251 still recruiting?

NCT04762251 is currently completed. Last updated 2 August 2024.

Last reviewed 2024-08-02 · How we verify

NCT04762251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

What Or When to Eat to Reduce the Risk of Type 2 Diabetes (WOW)

Completed NA Last updated 2 August 2024

What this trial tests

NA trial testing Time-restricted eating in Time-restricted Eating in 247 participants. Completed in 19 April 2024.

Timeline

17 February 2021

Primary endpoint
2 August 2023

19 April 2024

Quick facts

Lead sponsor	University of Adelaide
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	247
Start date	17 February 2021
Primary completion	2 August 2023
Estimated completion	19 April 2024
Sites	2 locations across Australia

Drugs / interventions tested

Time-restricted eating
Current Best Practice

Conditions studied

Time-restricted Eating — all drugs for Time-restricted Eating →
Diet Quality — all drugs for Diet Quality →

Sponsor

University of Adelaide

Who can join

Adults 35 to 70, any sex, with Time-restricted Eating or Diet Quality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A parallel, single-blinded, multi-centre randomized controlled trial conducted at the South Australian Health and Medical Research Institute (SAHMRI) and the Mary Mackillop Institute for Health Research (MMIHR; Australian Catholic University), by researchers from the University of Adelaide, Australian Catholic University and La Trobe University.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Time-restricted eating: Watching the clock to treat obesity.
Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, et al · · 2024 · cited 83× · PMID 38176412 · DOI 10.1016/j.cmet.2023.12.004
Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial.
Parr EB, Charrouf R, Hutchison AT, Flint SA, et al · · 2026 · PMID 42251202 · DOI 10.1007/s00125-026-06762-x
Effect of time restricted eating versus current practice in dietetics on glycaemic control and cardio-metabolic outcomes in individuals at risk of developing type 2 diabetes: Protocol for a multi-centre, parallel group, non-inferiority, randomised controlled trial.
Charrouf R, Parr EB, Hutchison AT, Flint SA, et al · · 2024 · PMID 39299545 · DOI 10.1016/j.cct.2024.107696

Verify or expand the search:

Other trials of Time-restricted eating

Trials testing the same drug.

NCT06802172 — Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · NA · recruiting
NCT07272460 — Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial · NA · recruiting
NCT06548191 — TREAD: Time Restricted Eating Intervention for Alzheimer's Disease · Phase 1 · recruiting
NCT06482515 — Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue · Phase 2 · recruiting
NCT06504342 — Clocks in Sync - Circadian Rhythm and Bipolar Mania · NA · completed

Other recruiting trials for Time-restricted Eating

Currently open trials in the same condition.

NCT07215533 — Effects of HIIT vs. TRE on Type 2 Diabetes Risk · NA · recruiting
NCT03802253 — Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial) · NA · active not recruiting

Other University of Adelaide trials

Trials by the same sponsor.

NCT07013656 — Effects of Combined Administration of Calcium and L-tryptophan on Gut Functions and Blood Glucose in Healthy Humans · NA · not yet recruiting
NCT06890507 — The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA) · Phase 2 · not yet recruiting
NCT06942195 — Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes · NA · recruiting
NCT05682339 — Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control · NA · completed
NCT05769335 — Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04762251 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Adelaide
Last refreshed: 2 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing